0

Global Peanut Allergy Therapeutics Market 2019-2023

  • Published: Nov 2018
  • Pages: 109
  • SKU: IRTNTR30114
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global peanut allergy therapeutics market is forecasted to register a speedy growth over the next five years owing to increasing number of research grants for the development of peanut allergy therapy. Wondering how to make the most of this booming peanut allergy industry? Technavio’s extensive industry research report offers detailed insights that will allow you to take full advantage of the opportunities available to you. This study provides an in-depth analysis of the market by considering the evolving demographics and consumer behavior in the peanut allergy therapeutics market. It also examines the competitive landscape and some key peanut allergy therapy companies including Aimmune Therapeutics, Aravax, and DBV Technologies.

Want to get a preview about how you can gain crucial information from Technavio’s market research report? Check out the latest facts about the peanut allergy therapeutics industry

Peanut Allergy Therapeutics Market

The global peanut allergy therapeutics market is expected to grow at a colossal CAGR of almost 90% during the forecast period

Peanut allergy industry growth is expected to grow at a mammoth rate over the next five years driven by the increase in collaborations for R&D. Drug development and marketing is an expensive and lengthy affair in the pharmaceutical industry as the peanut allergy therapy companies need extensive funding, advanced manufacturing units, and a strong distribution network. Several peanut allergy therapy companies are engaging in collaborations to gain a strong foothold on funds and skill set to develop novel peanut allergy treatment methods. Another factor behind the rapid growth of the global peanut allergy market is the growing prevalence of various types of food allergy, including peanut allergy in many developed countries. Technavio’s peanut allergy industry analysis reveals promising markets around the world.

Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Americas will drive the largest incremental growth for peanut allergy therapeutics market

The Americas will drive almost 47% of the growth for the global peanut allergy market, while EMEA and APAC are also predicted to make sizeable contributions to the incremental growth in the forecast period. Towards the end of 2018, the Americas dominated the global peanut allergy market with a market share of over 47%, followed by EMEA and APAC. In addition, the Americas are expected to retain their dominant market position through the period of forecast, while, APAC is anticipated to display the fastest rate of growth in comparison to EMEA and the Americas over the next five years.

Aimmune Therapeutics, Aravax, and DBV Technologies are among the leading peanut allergy therapy companies

The global peanut allergy market is forecasted to grow marginally less concentrated over the next five years owing to the presence of a few peanut allergy therapy companies that offer products such as peanut protein and vaccines. Some of the leading peanut allergy therapy companies are conducting extensive R&D on developing drugs and using peanut protein as immunotherapy for peanut allergy. Many international and regional vendors are vying for their share of the peanut allergy market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

  • Aimmune Therapeutics
  • Aravax
  • DBV Technologies
  • HAL Allergy
  • Immunomic Therapeutics

We can help! Our analysts can customize this report to meet your requirements. Get in touch

 

Read More Read Less

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Peanut protein - Market size and forecast 2018-2023
  • Vaccine - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • Americas - Market size and forecast 2018-2023
  • EMEA - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Aimmune Therapeutics
  • Aravax
  • DBV Technologies
  • HAL Allergy
  • Immunomic Therapeutics

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>